Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

75.0%

3 terminated/withdrawn out of 4 trials

Success Rate

25.0%

-61.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 1
3(100.0%)
3Total
Phase 1(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT02907593Phase 1Terminated

Steroids and Surfactant in Extremely Low Gestation Age Infants Dose Escalation Trial

Role: collaborator

NCT02121132Completed

Pediatric Obesity Weight Evaluation Registry (POWER) Study

Role: collaborator

NCT01343394Phase 1Withdrawn

Safety of Autologous Human Umbilical Cord Blood Mononuclear Fraction to Treat Acquired Hearing Loss in Children

Role: collaborator

NCT01328860Phase 1Terminated

Autologous Stem Cells for Spinal Cord Injury (SCI) in Children

Role: collaborator

All 4 trials loaded